HCG is all set to post strong earnings for FY24 and FY25 as its new centers continue to mature. Earnings growth should also be assisted by 300-400bp expansion in EBITDA margin (currently at 18%).
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.